General Archive

Home » Our science » Page 2
  • Defocused image of people at a conference

    Pharma Integrates

    About the event Pharma Integrates is a premier event uniting leaders across the pharmaceutical pipeline to address their needs, exchange…

    Read more

  • Amyloid plaques aggregates, 3d illustration
    News releases

    Two major UK decisions announced on use of Alzheimer’s drug, lecanemab

    Today, two major decisions have been made on lecanemab (Leqembi®) – the Alzheimer’s drug that we helped humanise, which slows the…

    Read more

  • Kevin Gillen, LifeArc
    Articles

    LifeArc contributes to organic chemistry breakthrough

    The findings reveal that seemingly impossible chemical reactions can be driven through a phenomenon called quantum tunnelling.

    Read more

  • Kovilen-Sawmynaden-2017
    Articles

    Study reveals potential new way to treat colorectal cancer

    Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.

    Read more

  • News releases

    TYSABRI gains market approval

    Biogen Idec and Elan Corporation yesterday announced the approval of a supplemental Biologics License Application (sBLA) by the U.S. Food…

    Read more

  • Antibody vector graphic
    News releases

    Therapeutic Antibody Group starts

    The Therapeutic Antibody Group (TAG) will comprise former AERES scientists. As part of MRCT’s evolving strategy of adding significant value…

    Read more